Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Khan, , Russell,
DOB:	29-AUG-1980 (Age: 45)
Gender:	male
Address:	1 Holly well B9 Allantown (United Kingdom)
ID:	7982-255119-2 (ECI)

Report
Date:	02-JAN-2022

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Birmingham Children's Hospital B4 6 Birmingham (United Kingdom)

Specimen
Collected:	02-JAN-2022

Chemistry

Test	02-JAN-2022	Reference Range	Unit
Cholesterol [Mass/volume] in Serum or Plasma	165.6	0 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	126.6	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	78.2	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	62.1 H	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All lipid parameters are within or slightly above the optimal range. Total cholesterol, triglycerides, and LDL are normal. HDL is mildly elevated, which is generally considered protective against cardiovascular disease. No laboratory evidence of dyslipidemia; results are favorable from a cardiovascular risk perspective. No action required.